Bacteriologic and clinical efficacy of one day vs. three day intramuscular ceftriaxone for treatment of nonresponsive acute otitis media in children

Pediatric Infectious Disease Journal

Volumn 19, Issue 11, 2000, Pages 1040-1045

  Leibovitz, Eugene ^a,b   Piglansky, Lolita ^a,b   Raiz, Simon ^a,b   Press, Joseph ^a,b   Leiberman, Alberto ^a,b   Dagan, Ron ^a,b  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Acute otitis media; Ceftriaxone; Efficacy; Streptococcus pneumoniae

Indexed keywords

CEFTRIAXONE; PENICILLIN DERIVATIVE;

ACUTE DISEASE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MORAXELLA CATARRHALIS; MYRINGOTOMY; OTITIS MEDIA; PENICILLIN RESISTANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; STREPTOCOCCUS PNEUMONIAE;

ACUTE DISEASE; BACTERIA; CEFTRIAXONE; CEPHALOSPORINS; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INJECTIONS, INTRAMUSCULAR; MALE; OTITIS MEDIA; PROSPECTIVE STUDIES; RECURRENCE;

EID: 0033710807     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200011000-00003     Document Type: Article

References (32)

1. Epidemiology and in vitro susceptibility of drug-resistant Streptococcus pneumoniae
2. Increasing importance of antibiotic-resistant Streptococcus pneumoniae in acute otitis media
3. Causative pathogens, antibiotic resistance and therapeutic considerations in acute otitis media
4. Prevalence of antimicrobial-resistant pathogens in middle ear fluid: Multinational study of 917 children with acute otitis media
5. Impaired bacteriologic response to oral cephalosporins in acute otitis media caused by pneumococci with intermediate resistance to penicillin
6. Bacteriologic response to oral cephalosporins: Are established susceptibility breakpoints appropriate in the case of acute otitis media?
7. Acute otitis media: Management and surveillance in an era of pneumococcal resistance: A report from the Drug-resistant Streptococcus pneumoniae Therapeutic Working Group
8. Persistent acute otitis media: I. Causative pathogens
9. Persistent acute otitis media: II. Antimicrobial treatment
10. Bacteriology of acute otitis media unresponsive to initial antimicrobial therapy
11. Microbiology of recently treated acute otitis media compared with previously untreated acute otitis media
12. Resistance pattern of middle ear fluid isolates in acute otitis media recently treated with antibiotics
13. Influence of recent antibiotic therapy on antimicrobial resistance of Streptococcus pneumoniae in children with acute otitis media in Spain
14. Bacteriologic efficacy of a three-day intramuscular ceftriaxone regimen in nonresponsive acute otitis media
15. Treatment failure in otitis media
16. Single intramuscular dose of ceftriaxone as compared to 7-day amoxicillin therapy for acute otitis media in children: A double blind clinical trial
17. Single-dose intramuscular ceftriaxone for acute otitis media in children
18. Single-dose ceftriaxone versus 10 days of cefaclor for acute otitis media
19. Comparison of ceftriaxone and trimethoprim-sulfamethoxazole for acute otitis media
20. Intramuscular ceftriaxone compared with oral amoxicillin-clavulanate for treatment of acute otitis media in children
21. One dose ceftriaxone vs. Ten days of amoxicillin/clavulanate therapy for acute otitis media: Clinical efficacy and change in nasopharyngeal flora
22. Eradication by ceftriaxone of Streptococcus pneumoniae isolates with increased resistance to penicillin in cases of acute otitis media
23. The Quellung reaction, a neglected microbiologic technique
24. Performance standards for antimicrobial susceptibility testing: Sixth Informed Supplement
25. Single-dose pharmacokinetics of ceftriaxone in infants and young children
26. Human pharmacokinetics and distribution in various tissues of ceftriaxone
27. Ceftriaxone: A review of its antibacterial activity, pharmacological properties and therapeutic use
28. Penetration of ceftriaxone into the middle ear fluid of children
29. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media
30. Dynamics of nasopharyngeal pneumococcal carriage in children with non-responsive acute otitis media treated with 2 regimens of intramuscular ceftriaxone [Abstract 1027]
31. Prescribing antimicrobial agents for treatment of acute otitis media
32. Review of consensus reports on the management of acute otitis media